Showing results (1-10 of 123) with videos related to
Sort By:
Pageof 13
Endoscopy|November 1, 1976
Peritoneoscopic evaluation of the effect of chemotherapeutic agents on liver metastases of breast cancer (report of 2 cases)H Bleiberg, M Rozencweig, D Gangii, et al.European Journal of Cancer & Clinical Oncology|May 1, 1985
Cisplatin plus vindesine in advanced breast cancer: a phase II trial of the EORTC Breast Cancer Cooperative GroupR Paridaens, A Clarysse, M Rozencweig, et al.Cancer Treatment Reports|October 1, 1976
Current overview of EORTC clinical trials with tamoxifenJ C HeusonActa Chirurgica Belgica|March 1, 1980
Implications of adjuvant hormonal and cytotoxic chemotherapyJ C HeusonEuropean Journal of Cancer & Clinical Oncology|January 1, 1982
N-(phosphonacetyl)-L-aspartate (PALA) in advanced breast cancer: a phase II trial of the EORTC breast cancer cooperative groupR Paridaens, H T Mouridsen, T Palshof, et al.Archiv Fur Geschwulstforschung|January 1, 1975
Significance of tissue estrogen receptors in the strategy of breast cancer treatmentJ C Heuson, G LeclercqJournal of Receptor Research|January 1, 1990
Estrogenic and antiestrogenic down-regulation of estrogen receptor levels: evidence for two different mechanismsM Gyling, G Leclercq, J C HeusonJournal of Steroid Biochemistry|July 1, 1983
Guide-lines in the design of new antiestrogens and cytotoxic-linked estrogens for the treatment of breast cancerG Leclercq, N Devleeschouwer, J C HeusonClinical Endocrinology|December 1, 1983
Effects of aminoglutethimide on adrenal steroid secretionA Vermeulen, R Paridaens, J C HeusonPathologie-Biologie|December 1, 1983
[Relation between estrogen and progesterone receptors and response to hormone therapy]G Leclercq, R Paridaens, J C HeusonPageof 13